What the Peer-Reviewed Record Establishes
The primary research record in Translational & Geroprotective Reproductive Biology is stratified by study design so that meta-analyses and replicated randomised controlled trials (T1–T2) carry greater epistemic weight than observational cohorts (T3–T4) or preclinical laboratory work (T5). Leading graded findings establish the core empirical baseline: [T1] STUDY QUESTION: What is the present performance of artificial intelligence (AI) decision support during embryo selection compared to the standard embryo selection by embryologists? [57] [T1] The disease, especially at the ovarian site has been shown to have a detrimental impact on ovarian physiology. [88]
Further clinical and mechanistic stratification across the literature demonstrates: [T3] Embryo selection within in vitro fertilization (IVF) is the process of evaluating qualities of fertilized oocytes (embryos) and selecting the best embryo(s) available within a patient cohort for subsequent transfer or cryopreservation. [72] [T4] Maternal Spindle Transfer (MST) replaces senescent oocyte cytoplasm with enucleated donor cytoplasm while preserving 100% of the mother's nuclear chromosomes, rescuing blastocyst progression and achieving live births in previously arrested IVF cohorts. [59]
Comparative Evaluation of Levers & Theoretical Models
When evaluated as a quantitative decision and mechanism ledger, the best-supported interventions and frameworks in Translational & Geroprotective Reproductive Biology are: In Vitro Activation (IVA) of Dormant Primordial Follicles (Targeted — Triggers CCN growth factor synthesis and awakens silent primordial follicles into gonadotropin-responsive antral waves; landmark evidence: Kawamura et al., PNAS 2013; Suzuki et al.; Diaz-Garcia et al.: Offered in specialized centers in Japan (St. Marianna / Kawamura) and Spain for severe diminished ovarian reserve.).
By contrast, interventions and hypotheses that remain experimental, subgroup-restricted, or unsupported by randomised endpoints include: Maternal Spindle Transfer (MST) & Pronuclear Transfer (PNT) (Trial only — Restores blastocyst progression in arrested cohorts; 6 live births with <1% maternal mtDNA carryover and normal pediatric follow-up; Ideal when oocytes fertilize or retrieve but arrest before blastocyst due to cytoplasmic ATP failure, preserving 100% maternal + paternal nuclear DNA.); iPSC-Derived Ovarian Support Cells (Gameto Fertilo EE-IVM) (Trial only — Boosts ex vivo MII maturation and euploid blastocyst formation after only 1–3 days of mild gonadotropin stimulation; Provides young cellular nurse support in the petri dish without altering the egg's autologous genome.); Low-Dose Rapamycin (mTORC1 Modulation) (Trial only — Preserves primordial follicle pool, reduces stromal inflammaging, and extends functional ovarian window; Requires washout prior to embryo transfer; active human clinical trial at Columbia University.).
Within the Tree of Knowledge, this field branches into 27 specialised sub-disciplines: AI-Driven Embryo Selection & Morphokinetics (Utilizing computer vision and deep learning on time-lapse imaging to predict implantation potential and live birth outcomes more accurately than manual grading); Antioxidants (Evaluation of Coenzyme Q10 and Melatonin in mitigating age-related oxidative stress within the follicular fluid and oocyte mitochondria); Bioethics and Legislation, Medical (Global regulatory frameworks, the legal status of germline modification, and the ethical debate surrounding 'three-parent' embryos); Cell-Free Secretomes and Extracellular Vesicles (Explores purified autologous or allogeneic mesenchymal stem cell secretomes, microRNAs, and exosome cargo as non-cellular alternatives to direct cellular grafting); Energy Metabolism (Evaluation of oxidative phosphorylation, ATP synthesis rates, and metabolic substrate utilization in developing oocytes and spermatozoa).
Evolution of the Field, Open Debates & Active Trials
Chronologically, the field evolved through key inflection points: in 1990, DENSITY SEPARATION OF ZYGOTIC AND SOMATIC EMBRYOS (Density changes associated with developing zygotic embryos of loblolly pine (Pinus taeda L.) and somatic embryos of celery (Apium graveolens L.) were determined using sucrose gradients); in 2016, Ovarian ageing: the role of mitochondria in oocytes and follicles (BACKGROUND: There is a great inter-individual variability of ovarian ageing, and almost 20% of patients consulting for infertility show signs of premature ovarian ageing); in 2018, Human Oogonia Generated from Adult Somatic iPSCs (Mitinori Saitou's laboratory (Kyoto University) differentiates human iPSCs into oogonia in Science); in 2020, NMN / NAD+ Repletion Rescues Aged Oocyte Fertility (UNSW and Harvard researchers show NAD+ repletion restores spindle assembly and live births).
Contested and frontier findings currently under investigation include: [T4 · Debated] Maternal Spindle Transfer (MST) replaces senescent oocyte cytoplasm with enucleated donor cytoplasm while preserving 100% of the mother's nuclear chromosomes, rescuing blastocyst progression and achieving live births in previously arrested IVF cohorts. (Costa-Borges et al., Fertility and Sterility 2023 prospective trial (n=25).) [T5 · Frontier / fringe] BACKGROUND: There is a great inter-individual variability of ovarian ageing, and almost 20% of patients consulting for infertility show signs of premature ovarian ageing. (Extracted from primary animal literature (2016, 577 citations).)
Open Questions & Priorities for the Next Research Sweep
Methodological priorities and open empirical questions queued for the next research sweep across Translational & Geroprotective Reproductive Biology focus on resolving subgroup effect sizes, causal mechanisms, and long-term outcomes:
- Germinal Vesicle Transfer (GVT) at Prophase I prior to Meiosis I chromosome segregation so young donor cytoplasm guides the entire first meiotic division
- Standardized human clinical dosing and follicular fluid pharmacokinetics of oral spermidine and nicotinamide mononucleotide (NMN)
- Reconstitution of error-free human meiotic prophase and chromosome crossover from iPSC-derived oogonia in In Vitro Gametogenesis (IVG)
- Large-scale multicentre randomised controlled trials with standardised live-birth and long-term offspring follow-up in Frontier fertility treatments.
- Age- and subgroup-stratified biomarker validation across diverse human populations.
- Germinal Vesicle Transfer (GVT) preclinical models transferring Prophase I nuclei into young cytoplasm before Meiosis I chromosome segregation